What We Do
Defective Medical Products
- Defective Medical Products Blog Home
- AMO Complete Moistureplus Recall
- Apothecure Colchicine Lawsuit
- Guidant
- Heparin Induced Thrombocytopenia Thrombosis
- Ketek Liver Failure
- Ortho Evra Birth Control Patch
- Trasylol
Previous Posts
- Herbal Science International Recall: Dietary Herba...
- Selenium in Total Body Formula
- Baxter Heparin Recall Investigation Update
- Fentanyl Patch Recall
- B. Braun Heparin Syringe Recall
- Heparin Recall
- Medication Error Links
- Bumetanide and Norepinephrine: Look-Alike Vials
- Medtronic Defibrillator Lead Recall and Lawsuit
- Haldol (Haloperidol)
Archives
Subscribe to
Posts [Atom]
Pritzker | Ruohonen Defective Medical Products Blog
B. Braun Heparin Syringe Recall
B. Braun Medical Inc. was recently notified by its contract manufacturer, AM2PAT Inc., of a nationwide recall of all lots and sizes of Pre-filled Heparin and Saline Flush Syringes. (Read about the AM2Pat Inc. Heparin Recall.) This recall has prompted B. Braun Medical to recall its affected products, which includes the following Heparin syringes and normal saline flush syringes:- Normal Saline 3mL in 12 mL Syringe, Catalog #513584
- Normal Saline 5mL in 12 mL Syringe, Catalog #513586
- Normal Saline 10mL in 12 mL Syringe, Catalog #513587
- 10 units/mL Heparin, 5mL in 12 mL Syringe, Catalog #513610
- 100 units/mL Heparin, 3mL in 12 mL Syringe, Catalog #513611
- 100 units/mL Heparin, 5mL in 12 mL Syringe, Catalog #513612
Customers that have the recalled product in their possession should discontinue use immediately. Based on ongoing FDA inspection of AM2PAT Inc.'s facility, and CDC investigation it has been determined that there is a potential for the sterility of these affected products to be compromised, which may result in potential contamination. AM2PAT previously initiated a recall of one lot of Sierra Pre-Filled Heparin (lot #070926H) that was found to be contaminated with Serratia marcescens, which may lead to patient infections. CDC has confirmed growth of Serratia marcescens from several unopened syringes of this product in this specific AM2PAT lot. This type of bacterial infection could present a serious adverse health consequence that could lead to life-threatening injuries and/or death.
We are investigating cases involving Heparin products. To contact a lawyer at Pritzker | Ruohonen, please call toll-free at 1-888-377-8900 or submit the firm's free case consultation form.
Labels: B. Braun Heparin Syringe Recall, B. Braun Recall, Serratia marcescens
Free Case Consultation
Firm News
Fred Pritzker Listed in The Best Lawyers in America
Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.
Pain and Suffering
Rich Ruohonen recently chaired a legal seminar on obtaining compensation for pain and suffering in a personal injury case. Rich uses his knowledge, experience, and reputation to maximize recoveries for clients.
Medtronic Recall and Medtronic Lawsuit
FDA has annonced a Medtronic Spring Fidelis defibrillator lead recall. Two of our clients with defective Medtronic leads were shocked over twenty times before medical professionals were able to turn off the defibrillator.
Fleet Lawsuit
We are representing several people who experienced kidney failure (acute phosphate nephropathy) after use of Fleet Phospho-soda solution or Fleet Accu-Prep solution for bowel cleansing.
Ortho Evra Lawsuit: Ortho Evra Birth Control Patch
The Ortho Evra birth control patch has been linked to an increased risk of blood clots that can lead to pulmonary embolism, stroke and heart attack.
Trasylol Recall
Bayer has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.
Fentanyl Lawsuit and Fentanyl Recall
There have been a number of recalls regarding fentanyl due to the risk of a fentanyl overdose.
Fosamax and Osteonecrosis
Several cases of bisphosphonate-associated osteonecrosis of the jaw have been associated with the use of oral bisphosphonates, including Fosamax®, Actonel®, and other medications.
